Cvs Health Corp Stock Probability Of Bankruptcy

Name: CVS Health Next Financial Report
Start: 2024-05-01
End: 2024-05-01
Location: CVS Health Corp

CVS Stock

USD 68.60 0.43 0.62%

CVS Health's odds of distress is under 30% at this time. It has slight probability of undergoing some form of financial trouble in the near future. CVS Health's Probability of financial unrest is determined by interpolating and adjusting CVS Altman Z Score to account for off-balance-sheet items and missing or unfiled public information. All items used in analyzing the odds of distress are taken from the CVS balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out CVS Health Piotroski F Score and CVS Health Altman Z Score analysis.

Market Cap is likely to gain to about 95.9 B in 2024. Enterprise Value is likely to gain to about 91.1 B in 2024

CVS Health Corp Company probability of financial unrest Analysis

CVS Health's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current CVS Health Probability Of Bankruptcy

Less than 30%

Most of CVS Health's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CVS Health Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Our calculation of CVS Health probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting CVS Health odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of CVS Health Corp financial health.

Is CVS Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CVS Health. If investors know CVS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CVS Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.10)

Dividend Share

2.42

Earnings Share

6.47

Revenue Per Share

277.528

Quarterly Revenue Growth

0.12

The market value of CVS Health Corp is measured differently than its book value, which is the value of CVS that is recorded on the company's balance sheet. Investors also form their own opinion of CVS Health's value that differs from its market value or its book value, called intrinsic value, which is CVS Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CVS Health's market value can be influenced by many factors that don't directly affect CVS Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock	Good Will	Long Term Debt	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Long Term Investments	Net Working Capital	Capital Stock
Total Assets		0.97	0.97	0.91	0.94	1.0	0.98	0.83	0.95	0.94	0.96	0.99	0.95	-0.58	0.57	0.58	0.97	0.19	0.87	0.79	0.62	0.67	0.81	0.96	0.96	-0.82	0.72
Total Stockholder Equity	0.97		0.89	0.94	0.93	0.94	0.97	0.78	0.9	0.94	0.89	0.96	0.87	-0.6	0.53	0.66	0.91	0.24	0.77	0.78	0.53	0.61	0.8	0.88	0.9	-0.81	0.72
Net Debt	0.97	0.89		0.83	0.85	0.98	0.91	0.84	0.98	0.84	0.96	0.97	0.98	-0.55	0.65	0.53	0.95	-0.01	0.93	0.75	0.75	0.73	0.69	0.97	0.93	-0.73	0.6
Retained Earnings	0.91	0.94	0.83		0.95	0.89	0.96	0.8	0.82	0.99	0.78	0.92	0.82	-0.79	0.46	0.66	0.81	0.31	0.69	0.88	0.38	0.67	0.77	0.77	0.79	-0.78	0.73
Net Receivables	0.94	0.93	0.85	0.95		0.93	0.98	0.75	0.82	0.97	0.87	0.94	0.83	-0.58	0.4	0.66	0.9	0.46	0.7	0.86	0.37	0.58	0.92	0.85	0.87	-0.9	0.88
Total Liab	1.0	0.94	0.98	0.89	0.93		0.97	0.83	0.95	0.92	0.97	0.99	0.96	-0.56	0.57	0.55	0.97	0.17	0.89	0.79	0.64	0.68	0.81	0.97	0.96	-0.81	0.71
Total Current Assets	0.98	0.97	0.91	0.96	0.98	0.97		0.8	0.88	0.98	0.91	0.97	0.89	-0.64	0.49	0.6	0.93	0.32	0.78	0.83	0.48	0.63	0.86	0.89	0.91	-0.84	0.78
Short Term Debt	0.83	0.78	0.84	0.8	0.75	0.83	0.8		0.76	0.78	0.76	0.8	0.75	-0.6	0.55	0.55	0.78	-0.03	0.71	0.69	0.48	0.95	0.57	0.77	0.78	-0.73	0.52
Intangible Assets	0.95	0.9	0.98	0.82	0.82	0.95	0.88	0.76		0.81	0.93	0.96	0.99	-0.58	0.62	0.55	0.91	-0.07	0.94	0.73	0.79	0.66	0.62	0.94	0.89	-0.64	0.53
Accounts Payable	0.94	0.94	0.84	0.99	0.97	0.92	0.98	0.78	0.81		0.83	0.93	0.83	-0.71	0.46	0.59	0.86	0.4	0.71	0.86	0.36	0.62	0.85	0.81	0.84	-0.82	0.79
Common Stock	0.96	0.89	0.96	0.78	0.87	0.97	0.91	0.76	0.93	0.83		0.95	0.94	-0.39	0.52	0.45	0.99	0.15	0.89	0.68	0.66	0.6	0.8	1.0	0.99	-0.78	0.68
Good Will	0.99	0.96	0.97	0.92	0.94	0.99	0.97	0.8	0.96	0.93	0.95		0.96	-0.6	0.56	0.61	0.95	0.17	0.87	0.82	0.63	0.66	0.79	0.95	0.93	-0.79	0.71
Long Term Debt	0.95	0.87	0.98	0.82	0.83	0.96	0.89	0.75	0.99	0.83	0.94	0.96		-0.58	0.61	0.5	0.92	-0.03	0.95	0.75	0.77	0.65	0.65	0.95	0.9	-0.65	0.56
Treasury Stock	-0.58	-0.6	-0.55	-0.79	-0.58	-0.56	-0.64	-0.6	-0.58	-0.71	-0.39	-0.6	-0.58		-0.44	-0.39	-0.39	0.02	-0.53	-0.74	-0.26	-0.61	-0.26	-0.38	-0.39	0.28	-0.24
Property Plant Equipment	0.57	0.53	0.65	0.46	0.4	0.57	0.49	0.55	0.62	0.46	0.52	0.56	0.61	-0.44		0.27	0.46	-0.24	0.65	0.46	0.57	0.47	0.21	0.54	0.49	-0.28	0.1
Current Deferred Revenue	0.58	0.66	0.53	0.66	0.66	0.55	0.6	0.55	0.55	0.59	0.45	0.61	0.5	-0.39	0.27		0.51	0.13	0.33	0.65	0.34	0.47	0.51	0.48	0.45	-0.7	0.58
Short Term Investments	0.97	0.91	0.95	0.81	0.9	0.97	0.93	0.78	0.91	0.86	0.99	0.95	0.92	-0.39	0.46	0.51		0.2	0.85	0.71	0.62	0.62	0.84	0.99	0.99	-0.84	0.74
Net Tangible Assets	0.19	0.24	-0.01	0.31	0.46	0.17	0.32	-0.03	-0.07	0.4	0.15	0.17	-0.03	0.02	-0.24	0.13	0.2		-0.18	0.26	-0.54	-0.22	0.68	0.09	0.18	-0.49	0.7
Long Term Debt Total	0.87	0.77	0.93	0.69	0.7	0.89	0.78	0.71	0.94	0.71	0.89	0.87	0.95	-0.53	0.65	0.33	0.85	-0.18		0.71	0.79	0.63	0.51	0.91	0.87	-0.52	0.34
Capital Surpluse	0.79	0.78	0.75	0.88	0.86	0.79	0.83	0.69	0.73	0.86	0.68	0.82	0.75	-0.74	0.46	0.65	0.71	0.26	0.71		0.32	0.6	0.67	0.69	0.7	-0.71	0.57
Deferred Long Term Liab	0.62	0.53	0.75	0.38	0.37	0.64	0.48	0.48	0.79	0.36	0.66	0.63	0.77	-0.26	0.57	0.34	0.62	-0.54	0.79	0.32		0.45	0.18	0.7	0.61	-0.27	0.11
Short Long Term Debt	0.67	0.61	0.73	0.67	0.58	0.68	0.63	0.95	0.66	0.62	0.6	0.66	0.65	-0.61	0.47	0.47	0.62	-0.22	0.63	0.6	0.45		0.35	0.62	0.62	-0.55	0.33
Cash And Equivalents	0.81	0.8	0.69	0.77	0.92	0.81	0.86	0.57	0.62	0.85	0.8	0.79	0.65	-0.26	0.21	0.51	0.84	0.68	0.51	0.67	0.18	0.35		0.77	0.82	-0.93	0.94
Net Invested Capital	0.96	0.88	0.97	0.77	0.85	0.97	0.89	0.77	0.94	0.81	1.0	0.95	0.95	-0.38	0.54	0.48	0.99	0.09	0.91	0.69	0.7	0.62	0.77		0.98	-0.78	0.65
Long Term Investments	0.96	0.9	0.93	0.79	0.87	0.96	0.91	0.78	0.89	0.84	0.99	0.93	0.9	-0.39	0.49	0.45	0.99	0.18	0.87	0.7	0.61	0.62	0.82	0.98		-0.82	0.68
Net Working Capital	-0.82	-0.81	-0.73	-0.78	-0.9	-0.81	-0.84	-0.73	-0.64	-0.82	-0.78	-0.79	-0.65	0.28	-0.28	-0.7	-0.84	-0.49	-0.52	-0.71	-0.27	-0.55	-0.93	-0.78	-0.82		-0.89
Capital Stock	0.72	0.72	0.6	0.73	0.88	0.71	0.78	0.52	0.53	0.79	0.68	0.71	0.56	-0.24	0.1	0.58	0.74	0.7	0.34	0.57	0.11	0.33	0.94	0.65	0.68	-0.89

	2019	2020	2021	2022	2023	2024 (projected)
Return On Assets	0.0298	0.0311	0.0343	0.0189	0.0334	0.0646
Asset Turnover	1.15	1.16	1.25	1.41	1.43	2.23
Net Debt	83.3B	77.2B	66.6B	57.8B	71.2B	74.7B
Total Current Liabilities	53.3B	62.0B	67.8B	69.7B	79.2B	83.1B
Non Current Liabilities Total	105.0B	99.0B	89.8B	87.2B	93.9B	98.6B
Total Assets	222.4B	230.7B	233.0B	228.3B	249.7B	262.2B
Total Current Assets	50.3B	56.4B	60.0B	65.7B	67.9B	71.3B
Total Cash From Operating Activities	12.8B	15.9B	18.3B	16.2B	13.4B	14.1B

	Return On Equity	0.11
	Return On Asset	0.0368
	Profit Margin	0.02 %
	Operating Margin	0.04 %
	Current Valuation	154.98 B
	Shares Outstanding	1.26 B
	Shares Owned By Insiders	0.11 %
	Shares Owned By Institutions	82.80 %
	Number Of Shares Shorted	22.72 M
	Price To Earning	42.99 X
	Price To Book	1.13 X
	Price To Sales	0.24 X
	Revenue	357.78 B
	Gross Profit	53.46 B
	EBITDA	13.74 B
	Net Income	8.37 B
	Cash And Equivalents	12.95 B
	Cash Per Share	15.21 X
	Total Debt	79.39 B
	Debt To Equity	1.00 %
	Current Ratio	0.94 X
	Book Value Per Share	59.36 X
	Cash Flow From Operations	13.43 B
	Short Ratio	2.51 X
	Earnings Per Share	6.47 X
	Price To Earnings To Growth	1.00 X
	Target Price	86.76
	Number Of Employees	219 K
	Beta	0.51
	Market Capitalization	87.01 B
	Total Asset	249.73 B
	Retained Earnings	61.6 B
	Working Capital	(11.33 B)
	Current Asset	30.38 B
	Current Liabilities	23.17 B
	Annual Yield	0.04 %
	Five Year Return	2.81 %
	Net Asset	249.73 B
	Last Dividend Paid	2.42

	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm

Cvs Health Corp Stock Probability Of Bankruptcy

CVS Health Corp Company probability of financial unrest Analysis

Probability Of Bankruptcy

Normalized

Z-Score

Current CVS Health Probability Of Bankruptcy

CVS Probability Of Bankruptcy Driver Correlations

CVS Probability Of Bankruptcy Peer Comparison

CVS Health Main Bankruptcy Drivers

CVS Health ESG Sustainability

CVS Fundamentals

About CVS Health Fundamental Analysis

Pair Trading with CVS Health

Complementary Tools for CVS Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY